The values for glargine and ultralente were incorrect in Figure 3 in “Clarifying the Role of Insulin in Type 2 Diabetes Management” published in the last issue of
Clinical Diabetes ( 21:14–21, 2003)
. The online version of this article was corrected in departure from print and can be viewed in its entirety at http://clinical.diabetesjournals.org/cgi/content/full/21/1/14.
Figure 3.
The action of human insulins. Onset, peak, and usual effective durations vary among available insulins. In some reports, ultralente has demonstrated a peak concentration after several hours, followed by waning. Values shown are the mean in each range. Adapted with permission from Ref. 27.
Figure 3.
The action of human insulins. Onset, peak, and usual effective durations vary among available insulins. In some reports, ultralente has demonstrated a peak concentration after several hours, followed by waning. Values shown are the mean in each range. Adapted with permission from Ref. 27.
